Label: TRIAMCINOLONE-MOXIFLOXACIN PF injection, suspension
-
Contains inactivated NDC Code(s)
NDC Code(s): 71384-510-01 - Packager: Imprimis NJOF, LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated February 10, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- STORAGE AND HANDLING
- Package Label
-
INGREDIENTS AND APPEARANCE
TRIAMCINOLONE-MOXIFLOXACIN PF
triamcinolone-moxifloxacin pf injection, suspensionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:71384-510 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TRIAMCINOLONE ACETONIDE (UNII: F446C597KA) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA) TRIAMCINOLONE ACETONIDE 15 mg in 1 mL MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE (UNII: B8956S8609) (MOXIFLOXACIN - UNII:U188XYD42P) MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE 1 mg in 1 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:71384-510-01 20 in 1 BOX 01/05/2018 1 0.6 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/05/2018 Labeler - Imprimis NJOF, LLC (080431967) Registrant - Imprimis NJOF, LLC (080431967)
